Filing Details

Accession Number:
0001179110-17-011428
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-11 18:26:10
Reporting Period:
2017-08-11
Filing Date:
2017-08-11
Accepted Time:
2017-08-11 18:26:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1583107 Theravance Biopharma Inc. TBPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1302443 E Rick Winningham C/O Theravance Biopharma Us, Inc.
901 Gateway Boulevard
South San Francisco CA 94080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2017-08-11 10,000 $24.50 866,377 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct